172 related articles for article (PubMed ID: 14738407)
21. [Helicobacter pylori, gastric ulcer and non-steroidal anti-inflammatory agents].
Boixeda D; Gisbert JP; Cantón R; Alvarez Baleriola I; Bermejo F; Aller R; Martín de Argila C
Med Clin (Barc); 1996 Feb; 106(6):209-12. PubMed ID: 8667661
[TBL] [Abstract][Full Text] [Related]
22. [Gastroduodenal lesions and non-steroidal anti-inflammatory agents. What role does Helicobacter pylori play in this relationship?].
Gisbert JP; Boixeda D; Martín de Argila C; García Plaza A
Rev Esp Enferm Dig; 1998 Sep; 90(9):655-64. PubMed ID: 9780802
[TBL] [Abstract][Full Text] [Related]
23. Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study.
Arkkila PE; Seppälä K; Färkkilä MA; Veijola L; Sipponen P
Scand J Gastroenterol; 2006 Jul; 41(7):782-90. PubMed ID: 16785190
[TBL] [Abstract][Full Text] [Related]
24. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study.
Gisbert JP; Cruzado AI; Garcia-Gravalos R; Pajares JM
Hepatogastroenterology; 2004; 51(55):303-8. PubMed ID: 15011890
[TBL] [Abstract][Full Text] [Related]
25. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
[TBL] [Abstract][Full Text] [Related]
26. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study.
Demiray M; Gulten M; Manavoglu O; Evrensel T; Ulukaya E; Yerci O; Kanat O; Kurt E; Arslan M; Gonullu G; Demiray H; Gulten T; Memik F
Hepatogastroenterology; 2004; 51(59):1531-5. PubMed ID: 15362794
[TBL] [Abstract][Full Text] [Related]
28. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A
Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848
[TBL] [Abstract][Full Text] [Related]
29. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
[TBL] [Abstract][Full Text] [Related]
30. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer.
Kamada T; Hata J; Kusunoki H; Sugiu K; Tanimoto T; Mihara M; Hamada H; Kido S; Dongmei Q; Haruma K
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):98-102. PubMed ID: 16706819
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori eradication therapy: a randomized, controlled, prospective study.
Murakami K; Okimoto T; Kodama M; Tanahashi J; Mizukami K; Shuto M; Abe H; Arita T; Fujioka T
Scand J Gastroenterol; 2011 Mar; 46(3):287-92. PubMed ID: 21073372
[TBL] [Abstract][Full Text] [Related]
32. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
[TBL] [Abstract][Full Text] [Related]
33. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
[TBL] [Abstract][Full Text] [Related]
34. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
Peitz U; Raps S; Plein K; Leodolter A; Hotz Dagger J; Malfertheiner P
Dtsch Med Wochenschr; 2004 Mar; 129(13):671-5. PubMed ID: 15026962
[TBL] [Abstract][Full Text] [Related]
35. Variables influencing outcome of Helicobacter pylori eradication therapy in South China.
Cai W; Zhou L; Ren W; Deng L; Yu M
Helicobacter; 2009 Oct; 14(5):91-6. PubMed ID: 19751433
[TBL] [Abstract][Full Text] [Related]
36. Duplicate breath testing to confirm eradication of Helicobacter pylori: incremental benefit and cost in 419 patients.
Vakil N; Zullo A; Ricci C; Hassan C; Vaira D
Aliment Pharmacol Ther; 2008 Dec; 28(11-12):1304-8. PubMed ID: 18774949
[TBL] [Abstract][Full Text] [Related]
37. Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
Romano M; Marmo R; Cuomo A; De Simone T; Mucherino C; Iovene MR; Montella F; Tufano MA; Del Vecchio Blanco C; Nardone G
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):273-8. PubMed ID: 15017668
[TBL] [Abstract][Full Text] [Related]
38. [Effects of different triple therapies on duodenal ulcer-associated Helicobacter pylori infection and a one-year follow-up study].
Multiple Center Study Group In Beijing Area, China
Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1161-5. PubMed ID: 15387976
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of Helicobacter pylori eradication therapy in chronic liver disease.
Jung SW; Lee SW; Hyun JJ; Kim DI; Koo JS; Yim HJ; Park JJ; Lee HS; Chun HJ; Um SH; Choi JH; Kim CD; Ryu HS
Dig Liver Dis; 2009 Feb; 41(2):134-40. PubMed ID: 18436489
[TBL] [Abstract][Full Text] [Related]
40. Is there any correlation between 13C-urea breath test values and response to first-line and rescue Helicobacter pylori eradication therapies?
Gisbert JP; Olivares D; Jimenez I; Pajares JM
Dig Liver Dis; 2006 Apr; 38(4):254-9. PubMed ID: 16309984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]